Cover Image

Real-world effectiveness of GLP-1 receptor agonist-based treatment strategies on "time in range" in patients with type 2 diabetes

Background: Diabetes affects millions of people worldwide annually, and several methods, including medications, are used for its management; glucagon-like peptide-1 receptor agonists (GLP-1RAs) are one such class of medications. The efficacy and safety of GLP-1RAs in treating type 2 diabetes mellitu...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yongru Chen (Author), Jingxian Chen (Author), Shuo Zhang (Author), Dan Zhu (Author), Feiying Deng (Author), Rui Zuo (Author), Yufei Hu (Author), Yue Zhao (Author), Yale Duan (Author), Benwei Lin (Author), Fengwu Chen (Author), Yun Liang (Author), Jiaxiong Zheng (Author), Barkat Ali Khan (Author), Kaijian Hou (Author)
Format:	Book
Published:	Frontiers Media S.A., 2024-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy of polyethylene glycol loxenatide versus insulin glargine on glycemic control in patients with type 2 diabetes: a randomized, open-label, parallel-group trial
by: Shuo Zhang, et al.
Published: (2023)

GLP-1 receptor agonists and myocardial metabolism in atrial fibrillation
by: Jiani Zhong, et al.
Published: (2024)

GLP-1 agonists in treatment of obesity
by: Władysław Orłowski, et al.
Published: (2023)

Symptom Experience and Related Predictors in Liver Transplantation Recipients
by: Xiao Chen, et al.
Published: (2021)

Population pharmacokinetics of the GIP/GLP receptor agonist tirzepatide
by: Karen Schneck, et al.
Published: (2024)

Danuglipron - an innovate GLP agonist - literature short review
by: Agata Frańczuk, et al.
Published: (2024)

Potential Roles of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs) in Nondiabetic Populations
by: Dan Xu, et al.
Published: (2022)

INITIATING PATIENTS ON GLP-1/COMBINED GLP-1 AND GIP AGONISTS: A QUALITY IMPROVEMENT PROJECT
by: Shreya Srivastava, MD, MPH
Published: (2024)

Retatrutide - revolutionary recently developed GLP agonist - literature review
by: Patrycja Brzozowska, et al.
Published: (2024)

The GLP-1 agonist, liraglutide, ameliorates inflammation through the activation of the PKA/CREB pathway in a rat model of knee osteoarthritis
by: Qihong Que, et al.
Published: (2019)

Effect of GLP-1/GLP-1R on the Polarization of Macrophages in the Occurrence and Development of Atherosclerosis
by: Li Yang, et al.
Published: (2021)

Glucagon-like peptide-1 (GLP-1) agonists in the treatment of obesity
by: Magdalena Mazurek, et al.
Published: (2023)

The Impact of GLP-1 Agonists on Depression Treatment: A Literature Review
by: Paulina Lemieszek, et al.
Published: (2024)

GLP-1 Receptor Agonists and Coronary Arteries: From Mechanisms to Events
by: Aurélie Pahud de Mortanges, et al.
Published: (2022)

A potentially serious adverse effect of GLP-1 receptor agonists
by: Jinmiao Lu, et al.
Published: (2023)

The Use of GLP-1 Receptor Agonists in the Treatment of Obesity in Women with PCOS
by: Aleksandra Jaroń, et al.
Published: (2024)

Design and discovery of a highly potent ultralong-acting GLP-1 and glucagon co-agonist for attenuating renal fibrosis
by: Qian Zhao, et al.
Published: (2024)

Healthcare professionals' perceptions and management of obesity & knowledge of glucagon, GLP‐1, GIP receptor agonists, and dual agonists
by: W. Timothy Garvey, et al.
Published: (2024)

Baicalein: A potential GLP-1R agonist improves cognitive disorder of diabetes through mitophagy enhancement
by: Na Liu, et al.
Published: (2024)

External-stimuli responsive systems for cancer theranostic
by: Jianhui Yao, et al.
Published: (2016)

Designing a Dual GLP-1R/GIPR Agonist from Tirzepatide: Comparing Residues Between Tirzepatide, GLP-1, and GIP
by: Wang L
Published: (2022)

Salvianolic Acid B Inhibits Oxidative Stress in Glomerular Mesangial Cells Alleviating Diabetic Nephropathy by Regulating SIRT3/FOXO1 Signaling
by: Feiying Wen, et al.
Published: (2023)

Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events
by: Long He, et al.
Published: (2024)

GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art
by: Michael A. Nauck, et al.
Published: (2021)

Rational Design by Structural Biology of Industrializable, Long-Acting Antihyperglycemic GLP-1 Receptor Agonists
by: Lei Sun, et al.
Published: (2022)

Design of a highly potent GLP-1R and GCGR dual-agonist for recovering hepatic fibrosis
by: Nazi Song, et al.
Published: (2022)

Systematic investigation of the underlying mechanisms of GLP-1 receptor agonists to prevent myocardial infarction in patients with type 2 diabetes mellitus using network pharmacology
by: Guorong Deng, et al.
Published: (2023)

Association between different GLP-1 receptor agonists and acute pancreatitis: case series and real-world pharmacovigilance analysis
by: Hui Guo, et al.
Published: (2024)

GLP-1 Analogue Liraglutide Enhances SP-A Expression in LPS-Induced Acute Lung Injury through the TTF-1 Signaling Pathway
by: Tao Zhu, et al.
Published: (2018)

The Efficacy and Safety of the Combination Therapy With GLP-1 Receptor Agonists and SGLT-2 Inhibitors in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
by: Chen Li, et al.
Published: (2022)

A meta-analysis of the incidence of acne vulgaris in patients treated with GLP-1 agonists
by: Oluwafunke O. Ogunremi, BS, et al.
Published: (2024)

Impact of GLP-1 Receptor Agonists on Psoriasis and Cardiovascular Comorbidities: A Narrative Review
by: Haran K, et al.
Published: (2024)

Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK
by: Kristina S. Boye, et al.
Published: (2019)

GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms
by: Daiji Kawanami, et al.
Published: (2020)

A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond
by: Lalita Prasad-Reddy, et al.
Published: (2015)

Development of Syringaldehyde as an Agonist of the GLP-1 Receptor to Alleviate Diabetic Disorders in Animal Models
by: Jenpei Lee, et al.
Published: (2024)

Effect of GLP-1 Receptor Agonist on Ischemia Reperfusion Injury in Rats with Metabolic Syndrome
by: Marko Ravic, et al.
Published: (2024)

GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
by: Ji Hee Yu, et al.
Published: (2022)

Icariin Ameliorates Diabetic Renal Tubulointerstitial Fibrosis by Restoring Autophagy via Regulation of the miR-192-5p/GLP-1R Pathway
by: Zhirong Jia, et al.
Published: (2021)

Obesity medication lorcaserin activates brainstem GLP-1 neurons to reduce food intake and augments GLP-1 receptor agonist induced appetite suppression
by: Stefan Wagner, et al.
Published: (2023)